Bausch Health R&D program developed Xifaxan to treat Irritable bowel syndrome with diarrhea (IBS-D)

Bausch Health R&D program developed Xifaxan to treat Irritable bowel syndrome with diarrhea (IBS-D)
Unsplash Photo by Alexander Grey
Bausch Health Companies

Solutions - R&D

3: Good Health and Well-being
Written by
Oyelakin M. Jan 16th, 2024
Reviewed by

Register to read the full analysis —or— Upgrade to access more features

Comments

There is no comment yet.

#solutions #R&D #medicine #cure

Actual Direct Impact

Assess the impact materiality of this Topic for Bausch Health Companies

How negative/positive is the impact of Bausch Health Companies for this Topic?

How would you rate the severity of this impact?

Share this Analysis

Bausch Health Companies

Solutions - R&D

3: Good Health and Well-being
Written by
Oyelakin M. Jan 16th, 2024
Reviewed by

Keen to rectify an issue with this analysis?